Status:
COMPLETED
The Anti-fungal Effect of Miconazol Versus Miconazol-Loaded Chitosan Nanoparticles
Lead Sponsor:
Yasmine gamil
Conditions:
Oral Thrush
Eligibility:
All Genders
30-65 years
Phase:
PHASE1
Brief Summary
Objective: this study aimed to evaluate the therapeutic effects of topical application of miconazole and miconazole-loaded chitosan nanoparticles in treatment diabetic patients with oral candidiasis.
Detailed Description
Abstract: Objective: this study aimed to evaluate the therapeutic effects of topical application of miconazole and miconazole-loaded chitosan nanoparticles in treatment diabetic patients with oral ca...
Eligibility Criteria
Inclusion
- uncontrolled diabetes patients with oral candidiasis and their uncontrolled diabetes were confirmed by doing glycated hemoglobin test and their range is \>7.0%,
- age ranged from 30-65 years
- patients were willing to participate in this study
Exclusion
- immunocompromised and patients with systemic diseases that can cause muscle weakness as Parkinson's disease, or others that can limit their cognitive functioning such as dementia
- pregnant
- nursing women
- smokers
- alcoholic patients were also excluded from the study.
- should not have a history of use of any drugs that can cause hyposalivation or broad spectrum antibiotics, within the last month.
Key Trial Info
Start Date :
January 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 27 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06072716
Start Date
January 10 2023
End Date
July 27 2023
Last Update
October 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
radwa Elsherif
Giza, Egypt